Figure 1 Mast Cells per mm T-blue c-kit Rejecting Naive

Slides:



Advertisements
Similar presentations
Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.
Advertisements

Figure S1 A a b c 10× Ikkβ WT Ikkβ Mye  /  B C n=5, p
Three major problems that limit the clinical applications of transplantation are: morbidity/mortality associated with longterm immunosuppression “chronic.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
The reading is 7.38 mm. The reading is 7.72 mm.
מהפכות באנגליה.
A Deadly Path: Bacterial Spread During Bubonic Plague
From: Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis Invest. Ophthalmol. Vis. Sci ;57(3):
Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative.
David D. Yuh, MD, Kimberly L. Gandy, MD, Bruce A
Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:
a b c d Supplemental Figure S x108 IFU 2x108 IFU 28 28
TSLP Induces Mast Cell Development and Aggravates Allergic Reactions through the Activation of MDM2 and STAT6  Na-Ra Han, Hyun-A Oh, Sun-Young Nam, Phil-Dong.
Successful split thickness skin grafting in the presence of heavy colonisation with rare bacterium Aeromonas hydrophila: A case report  S. Koschel, T.G.
by Dennis Adeegbe, Robert B. Levy, and Thomas R. Malek
Mast Cells Condition Dendritic Cells to Mediate Allograft Tolerance
Volume 35, Issue 4, Pages (October 2011)
IL-21 Reduces Immediate Hypersensitivity Reactions in Mouse Skin by Suppressing Mast Cell Activation or IgE Production  Risa Tamagawa-Mineoka, Tsunao.
Volume 21, Issue 12, Pages (December 2017)
Cheryl Y. Chan, Ashley L. St. John, Soman N. Abraham  Immunity 
Volume 50, Issue 3, Pages (September 2006)
Induction of Thymic Stromal Lymphopoietin Expression in Keratinocytes Is Necessary for Generating an Atopic Dermatitis upon Application of the Active.
Days after cell inoculation Days after cell inoculation
Days after cell inoculation Days after cell inoculation
Preventing Allograft Rejection by Targeting Immune Metabolism
Tatjana Banovic, Kelli P. A. MacDonald, Kate A. Markey, Edward S
Γδ T Cells Augment Rejection of Skin Grafts by Enhancing Cross-Priming of CD8 T Cells to Skin-Derived Antigen  Azad Rahimpour, Stephen R. Mattarollo,
Mast Cells Contribute to Scar Formation during Fetal Wound Healing
Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative.
Antipruritic Effects of TRPV1 Antagonist in Murine Atopic Dermatitis and Itching Models  Jun-Won Yun, Jung A. Seo, Won-Hee Jang, Hyun Ju Koh, Il-Hong Bae,
Functional Beta2-Integrins Restrict Skin Inflammation In Vivo
P-Selectin Glycoprotein Ligand-1 Contributes to Wound Healing Predominantly as a P- Selectin Ligand and Partly as an E-Selectin Ligand  Hajime Tomita,
Deficiency of MyD88 Signaling in CD4 Tconvs Increases Tregs Suppression through Loss of ST2 Signaling, Reducing Acute Graft-Versus-Host Disease in Multiple.
Cell division Staining a root tip to observe mitosis.
De novo autoimmune hepatitis after liver transplantation
Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity  Andrea Braun, Nadin Dewert, Fiona Brunnert, Viktor.
Volume 20, Issue 13, Pages (September 2017)
Exacerbated and Prolonged Allergic and Non-Allergic Inflammatory Cutaneous Reaction in Mice with Targeted Interleukin-18 Expression in the Skin  Yusuke.
Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation  Jan Storek,
Superior Suppressive Capacity of Skin Tregs Compared with Lung Tregs in a Model of Epicutaneous Priming  Subhashree Mahapatra, Melanie Albrecht, Abdul.
Docosahexaenoic Acid Alleviates Atopic Dermatitis by Generating Tregs and IL-10/TGF- β-Modified Macrophages via a TGF-β-Dependent Mechanism  Sang-Chul.
Two Ancient Gene Families Are Critical for Maintenance of the Mammalian Skin Barrier in Postnatal Life  Michael Cangkrama, Charbel Darido, Smitha R. Georgy,
Takashi Ehara, Hidekazu Shigematsu  Kidney International 
Volume 60, Issue 1, Pages (July 2001)
Folinic Acid Supplementation in Higher Doses is Associated with Graft Rejection in Pediatric Hematopoietic Stem Cell Transplantation  Henric Lindqvist,
Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous- BMT Improves the Survival of Leukemia-Challenged Mice  Jenny Zilberberg,
Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression  Felix Locker, Silvia Vidali,
Mast Cells Condition Dendritic Cells to Mediate Allograft Tolerance
Full thickness skin grafting with marginal de-epithelialization of the wound: Experience with two cases  Graham William Sivyer  JPRAS Open  Volume 16,
SDC 3 - Figure S2 % of splenic CD4+CD25+Foxp3+ T cells d8 d15 d20.
Timothy J. Paradis, Susan H. Cole, Robin T. Nelson, Ronald P. Gladue 
Transcutaneous Gene Gun Delivery of hNC16A Induces BPAG2-Specific Tolerance  Monika Ettinger, Doris Peckl-Schmid, Christina Gruber, Martin Laimer, Josef.
Volume 42, Issue 2, Pages (February 2015)
Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches  Sarah-Jane Cozzi, Steven M. Ogbourne,
Power On & Skin Install RockOn! 2008.
IL-23 Antagonizes UVR-Induced Immunosuppression through Two Mechanisms: Reduction of UVR-Induced DNA Damage and Inhibition of UVR-Induced Regulatory T.
Volume 71, Issue 11, Pages (June 2007)
C A B * * * * HCC1954 HCC1569 Supplementary-Figure S5 Tumor cells sc.
CD160 on CD8+ T cells is required for optimal clearance of L
Fig. 2. Metachromatic staining of MMCs and CTMCs with toluidine blue or the chloroacetate esterase dyes. (A) Metachromatic staining with toluidine blue.
Ablation of PD-L1 in edited T3 sarcoma cells leads to augmented growth inhibition in WT mice. Ablation of PD-L1 in edited T3 sarcoma cells leads to augmented.
Par2 Inactivation Inhibits Early Production of TSLP, but Not Cutaneous Inflammation, in Netherton Syndrome Adult Mouse Model  Anaïs Briot, Matthieu Lacroix,
Molecular Therapy - Oncolytics
Fig. 4. The inhibition of mast cell infiltration by topical application of the TECA + AST combination in dorsal ear and back skin. Mast cell infiltrations.
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Combination CDN and PD-L1 mAb treatment of established MOC1 tumors produces consistent tumor rejection. Combination CDN and PD-L1 mAb treatment of established.
Ablation of Nf1 in HOXB7 lineage cells gives rise to diffuse cNF.
Volume 13, Issue 2, Pages (October 2015)
Supplementary Figure 1. The extrinsic acquisition of CD80 does not affect the cytotoxicity of Ag-specific memory CD8+ T cells. The LG and SP were obtained.
Figure 3. Representative photomicrographs in the control group
Presentation transcript:

Figure 1 Mast Cells per mm2 80 60 40 20 T-blue c-kit Rejecting Naive T-blue c-kit P = 0.001 Mast Cells per mm2 P = 0.003 Rejecting Naive Tolerant Syngeneic Figure 1

Figure 3 Mast Cells per mm2 (Toluidine-blue) Days post TX 120 100 80 60 40 20 P = 0.02 P = 0.1 Mast Cells per mm2 (Toluidine-blue) Naive Tolerant Syngeneic 100 0 7 14 50 100 Days post TX Figure 3

Figure 4 Mast Cells per mm2 (Toluidin-blue) 30 20 10 P = 0.9 P = 0.005 WT C3-/- C3aR-/- P = 0.4 P = 0.004 Mast Cells per mm2 (Toluidin-blue) P = 0.008 dLN LN dLN LN dLN LN Figure 4

A Figure 5 Mast Cells per mm2 (Toluidine-blue) Days post TX 120 100 80 60 40 20 Tolerant Rejecting Syngeneic P = 0.05 Mast Cells per mm2 (Toluidine-blue) P = 0.04 P = 0.9 P = 0.03 7 7 100 7 14 50 100 Days post TX Figure 5

A B Figure 6 Mast Cells per mm2 (Toluidine-blue) 80 60 40 20 WT C3-/- C3aR-/- 80 60 40 20 P = 0.016 P = 0.1 P = 0.029 Mast Cells per mm2 (Toluidine-blue) Mast Cells per mm2 (c-kit) P = 0.016 P = 0.5 P = 0.029 P = 0.9 WT C3-/- C3aR-/- P = 0.2 Naive skin Skin grafts Naive Naive Naive Graft Graft Graft Figure 6